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Introduction: Studies have shown many genes
influence antibiotic resistance, and the relationship
between genotypic and phenotypic antibiotic
resistance is unclear. We sought to analyze the
concordance between the presence of antibiotic
resistance (ABR) genes and antibiotic
susceptibility results in urine samples collected
from symptomatic UTI patients.
Methods: Urine samples were collected from
patients presenting with possible UTI to 37
geographically disparate Urology clinics from July
2018 to February 2019. Multiplex polymerase

chain reaction (M-PCR) was used to test for 33
different ABR genes. Samples in which at least
one organism was identified at a quantity of ≥104
cells per mL, Pooled Antibiotic Susceptibility
Testing (P-AST), which involves simultaneously
growing all detected bacteria together in the
presence of antibiotics and then measuring
susceptibility, was performed against 14 different
antibiotics. The concordance rate between the
ABR genes and the P-AST results was generated
for the overall group. The concordance rates for
each antibiotic between monomicrobial and
polymicrobial infection were compared using chisquare test.
Results: Among the 2,512 patients, bacteria were
detected in 1,579. ABR gene genotyping and PAST analysis was performed for 1,155. ABR
genes were detected in 36.3% (419/1155) of
specimens. Overall, the presence or absence of
ABR genes was 60% concordant with antibiotic
susceptibility patterns. Two circumstances
accounted for the concordance: ABR gene not
present by M-PCR/antibiotic sensitive by P-AST
(48.4%) and ABR gene present/antibiotic resistant
(11.5%). In the 40% non-concordant cases, 25%
were ABR gene not present/antibiotic resistant
and 15% were ABR gene present/antibiotic
sensitive, Table 1. Most antibiotics were
associated with similar concordance rates for
monomicrobial and polymicrobial infections.
However, the concordance rates were significantly
lower for polymicrobial for three antibiotics:
vancomycin, meropenem, and
piperacillin/tazobactam, with absolute differences
of 9.3% (p value=0.002), 13.1% (p value<0.0001),
and 19.0% (p value = 0.019), respectively.
Conclusion: The concordance rate of the ABR
genes as identified by M-PCR and phenotypic
resistance as detected by P-AST was 60%. Thus,
in 40% of samples, the reliance on the M-PCR
antibiotic resistance gene report without the
phenotypic data reported by P-AST data may lead
to inappropriate treatment.
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